A004 – Neurosciences

Research objectives

The main objective of the Neuroscience Area is to search for new therapeutic targets and improve the clinical-therapeutic management of neurological patients, mainly stroke, Alzheimer’s disease, Parkinson’s disease, headaches and neurological prion diseases.

  • Identification and validation of diagnostic and therapeutic targets in neurological diseases
  • Treatment of neurological diseases caused by prions
  • Study and treatment of nervous system tumors
  • The creation and application of new drugs
  • Cell and gene therapy
  • Study of the cellular and molecular mechanisms involved in neurological diseases
  • Nanomedicine applied to Neurosciences
  • Promotion and development of clinical trials in early phases
  • Development of clinical practice guidelines in neurological diseases

Research groups

Area leader

José Luis Labandeira García

José Luis Labandeira García

Area co-leader

A004 subcoordinador – Francisco Campos

Francisco Campos Pérez

El Dr. Francisco Campos hizo su formación postdoctoral en IIBB-CSIC (Barcelona) (2007-08), en el Instituto de Investigaciones Sanitarias de Santiago de Compostela (IDIS) (2009-10) y Massachusetts General Hospital-Harvard Medical School (2011-12). Desde 2013 es investigador Miguel Servet. Es autor d
Privacy overview

This website uses cookies so that we can offer you the best possible user experience. The cookie information is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team to understand which sections of the website you find most interesting and useful.